Hemochromatosis

312,270views

Hemochromatosis

MedSurg

MedSurg

Inflammation
Blood brain barrier
Blood products and transfusion: Clinical
Aplastic anemia
Thrombocytopenia: Clinical
Leukemias: Pathology review
Hemochromatosis
Anemia: Clinical
Myelodysplastic syndromes
Lymphoma: Clinical
Gastrointestinal system anatomy and physiology
Diabetes mellitus
Diabetes mellitus: Clinical
Diabetes mellitus: Pathology review
Cushing syndrome
Cushing syndrome and Cushing disease: Pathology review
Thyroid storm
Hashimoto thyroiditis
Thyroid hormones
Thyroid and parathyroid gland histology
Hyperthyroidism: Pathology review
Parathyroid conditions and calcium imbalance: Clinical
Anatomy of the thyroid and parathyroid glands
Hypoparathyroidism
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Diabetes insipidus
Diabetes insipidus and SIADH: Pathology review
Adrenal gland histology
Antidiuretic hormone
Synthesis of adrenocortical hormones
Parathyroid hormone
Adrenocorticotropic hormone
Growth hormone and somatostatin
Hypernatremia
Hyponatremia
Hypopituitarism
Pituitary gland histology
Non-alcoholic fatty liver disease
Non-Hodgkin lymphoma
Non-steroidal anti-inflammatory drugs
Insulins
Hypothyroidism: Pathology review
Graves disease
Preoperative evaluation: Clinical
Postoperative evaluation: Clinical
Type IV hypersensitivity
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Anaphylaxis
Shock
Antihistamines for allergies
Goodpasture syndrome
Guillain-Barre syndrome
HIV (AIDS)
HIV and AIDS: Pathology review
Asthma
Obstructive lung diseases: Pathology review
Chronic obstructive pulmonary disease (COPD): Clinical
Chronic bronchitis
Cystic fibrosis
Pneumothorax
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Reading a chest X-ray
Pleural effusion: Clinical
Emphysema
Bordetella pertussis (Whooping cough)
Pneumonia: Pathology review
Acute respiratory distress syndrome
Respiratory distress syndrome: Pathology review
Acute respiratory distress syndrome: Clinical
Pulmonary hypertension
Pulmonary edema
ECG basics
ECG normal sinus rhythm
ECG QRS transition
ECG intervals
Atrial fibrillation
Ventricular tachycardia
Myocardial infarction
ECG cardiac infarction and ischemia
Cardioversion
Anticoagulants: Warfarin
Anticoagulants: Heparin
Stroke volume, ejection fraction, and cardiac output
Shock: Clinical
Wolff-Parkinson-White syndrome
Coronary artery disease: Clinical
Hypoplastic left heart syndrome
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Long QT syndrome and Torsade de pointes
Hypertension
Hypertension: Clinical
Ventricular arrhythmias: Pathology review
Supraventricular arrhythmias: Pathology review
Ventricular fibrillation
Heart failure
Renin-angiotensin-aldosterone system
ACE inhibitors, ARBs and direct renin inhibitors
Polycystic kidney disease
Kidney stones
Kidney stones: Pathology review
Kidney stones: Clinical
Chronic pyelonephritis
Urinary tract infections: Pathology review
Nephritic and nephrotic syndromes: Clinical
Urinary incontinence
Urinary incontinence: Pathology review
Lower urinary tract infection
Urinary tract infections: Clinical
Glomerular filtration
Frank-Starling relationship
Pressures in the cardiovascular system
Neurogenic bladder
Non-urothelial bladder cancers
Valvular heart disease: Pathology review
Multiple sclerosis
Demyelinating disorders: Pathology review
Parkinson disease
Anti-parkinson medications
Movement disorders: Pathology review
Introduction to the somatic and autonomic nervous systems
Meningitis
Concussion and traumatic brain injury
Traumatic brain injury: Pathology review
Headaches: Clinical
Migraine medications
Headaches: Pathology review
Herpes simplex virus
Stroke: Clinical
Ischemic stroke
Subarachnoid hemorrhage
Dementia and delirium: Clinical
Huntington disease
Medications for neurodegenerative diseases
Osteoporosis
Cirrhosis
Rheumatoid arthritis
Rheumatoid arthritis: Clinical

Transcript

Watch video only

Hemochromatosis is a metabolic disorder where the body absorbs too much iron from the food you eat.

This accumulation of iron leads to elevated iron in the blood and poisoning of tissues in the liver, pancreas, heart, pituitary gland, joints and skin.

The root -chromat- actually refers to color or the darkening of the skin that happens when iron is deposited into it.

If we take a close look at our red blood cells, we’ll notice that they’re loaded with millions of copies of the same exact protein called hemoglobin, which binds to oxygen and turns our blood cells into little oxygen transporters, and basically allow us to move oxygen to all the tissues in our body.

If we take an even closer look at those hemoglobin proteins, we’ll find that they’re made of four heme molecules, which have, right in the middle, iron.

This iron molecule is what binds to oxygen, so without iron, we probably wouldn’t fare too well, right? Right.

Normally, you actually lose a small amount of iron every day, about 1 mg, some in the sweat, some in shedded skin cells, and some in shedded cells in the gastrointestinal tract.

Most of us, through the diet, take in 10-20 mg of iron every day, and absorb about 10% of that, so 1-2 mg, which is perfect!

People with hemochromatosis, though, absorb an unusually high amount of iron, sometimes as much as 4 mg per day, even though you probably only need about 1 mg to even out your losses, right?

You’d think that absorbing more of something is good, but in this case, a net gain of about 3 mg a day comes out to about 1 g per year of excess iron in your body, leading to more than 20 g by age 40!

Most of this iron you hold on to is deposited in your organs, most notably the liver, but also in your pancreas, your heart, joints, skin, and pituitary gland.

This process of depositing iron into organs is called hemosiderosis. But hey, a little hemosiderosis over the course of a lifetime never hurt anyone, right? Wrong!

Unfortunately, all this extra iron does start doing some serious damage because iron in the body is actually pretty good at generating free radicals through the fenton reaction.

The fenton reaction is where molecules of iron 2+ are oxidized by hydrogen peroxide, producing iron 3+ and the hydroxyl radical and hydroxide ion as byproducts; now, iron 3+ can then be reduced back to iron 2+ via hydrogen peroxide again, creating a peroxide radical and a proton, and then the cycle repeats, creating this like endless loop of free radical generation.

So, over time, all these deposits of iron slowly damage the cells in the various organs by free radical generation, which can cause cell death and then lead to tissue fibrosis. Dang.

Usually, since it takes so long to accumulate and for damage to set in, it’s not diagnosed until age 50 for men and usually 10 to 20 years after menopause for women, mostly because women have one extra method of getting rid of iron, which is through bleeding as part of the menstrual cycle.

Another, really important point that we skipped over, though, is why someone might absorb more iron than normal in the first place. Well, someone could have primary or secondary hemochromatosis.

Primary hemochromatosis is also sometimes called hereditary hemochromatosis, so I’m sure you can guess that it’s caused by a gene mutation, and it is, specifically in the HFE gene, which stands for High F-E, or iron, which is located on chromosome 6; this guy usually helps regulate how much iron we absorb from food.

People with this autosomal recessive disorder have a defect or mutation, though, either the C282Y mutation or H63D mutation, the former being more common.

This mutation specifically affects the absorptive cells in your small intestine, called enterocytes. These guys are super important for absorbing all sorts of things, including iron.

One awesome thing about them though, is that they only move the iron they absorbed into the blood when there’s a need to move it into the blood. So basically they regulate how much iron goes into your blood from your intestine.

With this mutation though, these enterocytes aren’t as good at regulating the iron, so most of the iron in your diet just goes right across from the gut through to your bloodstream, overloading the blood with iron.

If hemochromatosis is brought on by some other means besides a genetic mutation,it’s called secondary hemochromatosis. An example of secondary hemochromatosis is through frequent blood transfusions.

When you get new blood through the transfusion, after about 120 days those red blood cells die off and the iron they contain gets recycled, so each new bag of blood basically adds a bag of iron to your body. So lots of transfusions means lots of iron in the blood.

Sources

  1. "The transferrin receptor: the cellular iron gate" Metallomics (2017)
  2. "Diagnosis and Treatment of Genetic <i>HFE</i>-Hemochromatosis: The Danish Aspect" Gastroenterology Research (2019)
  3. "Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin" Gastroenterology (2015)
  4. "Robbins Basic Pathology" Elsevier (2017)
  5. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  6. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  7. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  8. "Diagnosis and management of hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases" Hepatology (2011)
  9. "Screening for Hereditary Hemochromatosis: Recommendations from the American College of Physicians" Annals of Internal Medicine (2005)